Nixon Peabody Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,054
| Closed | -$208K | – | 129 |
|
|
2023
Q4 | $208K | Buy |
+4,054
| New | +$208K | 0.02% | 127 |
|
|
2023
Q3 | – | Sell |
-20,510
| Closed | -$1.31M | – | 79 |
|
|
2023
Q2 | $1.31M | Sell |
20,510
-10,392
| -34% | -$665K | 1.06% | 42 |
|
|
2023
Q1 | $2.14M | Buy |
30,902
+44
| +0.1% | +$3.05K | 1.5% | 29 |
|
|
2022
Q4 | $2.22M | Buy |
30,858
+625
| +2% | +$45K | 1.8% | 19 |
|
|
2022
Q3 | $2.15M | Sell |
30,233
-3,596
| -11% | -$256K | 1.82% | 14 |
|
|
2022
Q2 | $2.61M | Buy |
33,829
+15,561
| +85% | +$1.2M | 1.18% | 46 |
|
|
2022
Q1 | $1.33M | Buy |
18,268
+12,097
| +196% | +$883K | 0.46% | 51 |
|
|
2021
Q4 | $385K | Buy |
+6,171
| New | +$385K | 0.12% | 69 |
|
|
2020
Q2 | – | Sell |
-4,000
| Closed | -$223K | – | 73 |
|
|
2020
Q1 | $223K | Buy |
+4,000
| New | +$223K | 0.14% | 66 |
|